510(k) K040451

VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896 by Pharmacia Deutschland GmbH — Product Code MSV

K040451 is an FDA 510(k) premarket notification submitted by Pharmacia Deutschland GmbH for the device "VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896". The FDA issued a decision of Substantially Equivalent on May 11, 2004. The device falls under product code MSV (System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)), a Class II device regulated under 21 CFR 866.5660. Pharmacia Deutschland GmbH has 9 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
May 11, 2004
Date Received
Feb 20, 2004
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)
Device Class
Class II
Regulation Number
866.5660
Review Panel
IM
Submission Type
510(k)

Need the full FDA record for Pharmacia Deutschland GmbH? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K040451. Report a data issue: hello@regdatalab.com.